1. Home
  2. SKIL vs ATNM Comparison

SKIL vs ATNM Comparison

Compare SKIL & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$6.25

Market Cap

40.2M

Sector

Technology

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.04

Market Cap

33.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKIL
ATNM
Founded
1998
2000
Country
United States
United States
Employees
2247
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
33.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SKIL
ATNM
Price
$6.25
$1.04
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
55.6K
105.9K
Earning Date
04-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
N/A
Revenue
N/A
$90,000.00
Revenue This Year
$0.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$3.43
$0.95
52 Week High
$18.45
$1.89

Technical Indicators

Market Signals
Indicator
SKIL
ATNM
Relative Strength Index (RSI) 38.82 36.75
Support Level $3.63 $0.99
Resistance Level $8.48 $1.27
Average True Range (ATR) 0.64 0.07
MACD -0.16 -0.02
Stochastic Oscillator 12.04 7.11

Price Performance

Historical Comparison
SKIL
ATNM

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: